Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,494 | 1,667 | 3,944 | 0 | 0 |
| Cost of Goods | 492 | 329 | 789 | N/A | 0 |
| Gross Profit | 1,002 | 1,338 | 3,155 | N/A | 0 |
| Operating Expenses | 10,211 | 30,281 | 9,196 | 4,712 | 4,945 |
| Operating Income | -8,717 | -28,614 | -5,252 | -4,712 | -4,945 |
| Interest Expense | 232 | 33 | 46 | 57 | 161 |
| Other Income | -83 | 1,806 | 28 | 36 | 0 |
| Pre-tax Income | -9,031 | -26,841 | -5,270 | -4,732 | -5,106 |
| Income Tax | -107 | -231 | 264 | 264 | 264 |
| Net Income Continuous | -8,924 | -26,610 | -5,534 | -4,997 | -5,370 |
| Net Income | $-8,924 | $-26,610 | $-5,534 | $-4,997 | $-5,370 |
| EPS Basic Total Ops | -0.08 | -0.27 | -0.06 | -0.06 | -0.08 |
| EPS Basic Continuous Ops | -0.08 | -0.27 | -0.06 | -0.06 | -0.08 |
| EPS Diluted Total Ops | -0.08 | -0.27 | -0.06 | -0.06 | -0.08 |
| EPS Diluted Continuous Ops | -0.08 | -0.27 | -0.06 | -0.06 | -0.08 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.27 | -0.06 | -0.06 | -0.08 |
| EBITDA(a) | $-6,817 | $-26,893 | $-4,679 | $-4,712 | $-4,945 |